Evidence map›Paper›PMID 39575251›Full record

ArticleFrontiers in immunology2024

Integrated analysis of single-cell, spatial and bulk RNA-sequencing identifies a cell-death signature for predicting the outcomes of head and neck cancer.

Yue Pan, Lei Fei, Shihua Wang, Hua Chen, Changqing Jiang, Hong Li, Changsong Wang, Yao Yang, Qinggao Zhang, Yongwen Chen

Abstract read
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yue PanInstitute of Immunology, People's Liberation Army (PLA), Third Military Medical University, Chongqing, China.
Lei FeiInstitute of Immunology, People's Liberation Army (PLA), Third Military Medical University, Chongqing, China.
Shihua WangDepartment of Pharmacy, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Hua ChenDepartment of Pharmacy, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Changqing JiangDepartment of Pharmacy, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Hong LiChongqing Renpin Otolaryngology Head and Neck Surgery Hospital, Chongqing, China.
Changsong WangDepartment of Pathology, People's Liberation Army Joint Logistic Support Force 989th Hospital, Luoyang, Henan, China.
Yao YangDepartment of Pharmacy, The General Hospital of Western Theater Command, Chengdu, Sichuan, China.
Qinggao ZhangChronic Disease Research Center, Medical College, Dalian University, Dalian, Liaoning, China.
Yongwen ChenInstitute of Immunology, People's Liberation Army (PLA), Third Military Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cell death plays an essential role in carcinogenesis, but its function in the recurrence and postoperative prognosis of head and neck cancer (HNC), which ranks as the 7 Methods: Data from five main subtypes of HNC related single-cell RNA sequencing (scRNA-seq) were recruited to establish a single-cell atlas, and the distribution of cell death models (CDMs) across different tissues as well as cell subtypes were analyzed. Bulk RNA-seq from the Cancer Genome Atlas Program (TCGA) dataset was subjected to a machine learning-based integrative procedure for constructing a consensus cell death-related signature risk score (CDRscore) model and validated by external data. The biofunctions including different expression analysis, immune cell infiltration, genomic mutations, enrichment analysis as well as cellchat analysis were compared between the high- and low- risk score groups categorized by this CDRscore model. Finally, samples from laryngeal squamous cell cancer (LSCC) were conducted by spatial transcriptomics (ST) to further validate the results of CDRscore model. Results: T cells from HNC patients manifested the highest levels of cell death while HPV infection attenuates malignant cell death based on single-cell atlas. CDMs are positively correlated with the tumor-cell stemness, immune-related score and T cells are infiltrated. A CDRscore model was established based on the transcription of ten cell death prognostic genes ( Conclusion: The CDRscore model could be utilized as a powerful prognostic indicator for HNC.

Indexed as

Head and Neck NeoplasmsSingle-Cell AnalysisBiomarkers, TumorCell DeathGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMalePrognosisRNA-SeqSequence Analysis, RNATranscriptomeBiomarkers, Tumorcell deathHNCmachine learningrisk scorespatial transcriptomics

Identifiers

PMID39575251
PMCPMC11578999

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.